Crossmark

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway

Crossref DOI link: https://doi.org/10.1038/s41698-018-0049-y

Published Online: 2018-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jeong, Woo-Jeong

Ro, Eun Ji

Choi, Kang-Yell
License Information

Text and Data Mining valid from 2018-02-20

Version of Record valid from 2018-02-20
More Information

Article History

Received: 29 December 2017

Revised: 23 January 2018

Accepted: 26 January 2018

First Online: 20 February 2018

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below